Operating income of Bausch Health 2012-2018

This statistic shows the timeline of the operating income of Valeant Pharmaceuticals from 2012 to 2018. The operating income of Bausch Health was 80 million U.S. dollars in 2012, and was in a loss of 566 million U.S. dollars in 2016. Bausch Health Companies Inc. was known as Valeant Pharmaceuticals until July 2018 when the name was changed under a new company leadership.

Operating income of Bausch Health Companies from 2012 to 2018

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2019

Region

Worldwide

Survey time period

2012 to 2018

Supplementary notes

This statistic was assembled from several of Valeant's/Bausch Health's annual reports.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.